Medical device company financing brought in $977 million, a decrease over Q1’s $1.1 billion. Device acquisition activity was up to $4.6 billion, yet only one deal surpassed the billion-dollar mark. With late-stage financing again leading, diagnostics funding together brought in $336 million, an 11% increase over Q1. For the first time since Q1 2011, the diagnostics M&A dollar total moved up instead of down, with $7 billion in acquisitions and five of the seven transactions topping $100 million.

START-UP’s monthly update on life science technology transfer deals--licensing agreements between companies and universities or other research institutions--in the fields in vitro diagnostics, pharmaceuticals, research/analytical equipment & supplies and medical devices.

A roundup of recent medtech mergers & acquisitions, strategic alliances, and financings.